Medicine and Dentistry
Acute Pulmonary Embolism
6%
Age
36%
Analysis
34%
Anticoagulant
15%
Anticoagulant Therapy
5%
Anticoagulation
22%
Antithrombotic
9%
Apixaban
7%
Apoplexy
5%
Arm
15%
Atrial Fibrillation
15%
Bleeding
18%
Blood Clot Lysis
15%
Blood Clotting Factor 10a Inhibitor
47%
Blood Stasis
16%
Cancer Treatment
15%
Child
15%
Chronic Kidney Disease
15%
Chronic Thromboembolic Pulmonary Hypertension
11%
Clinical Trial
20%
Deterioration
7%
Direct Oral Anticoagulant
15%
Embolism
5%
Follow up
12%
Glomerular Filtration Rate
13%
Hazard Ratio
10%
Hemostat
17%
Hospital
8%
Kidney Function
15%
Low Molecular Weight Heparin
5%
Major Bleeding
68%
Menorrhagia
15%
Patient
100%
Patient Selection
15%
Post-Hoc Analysis
17%
Pulmonary Embolism
35%
Rivaroxaban
58%
Sequela
15%
Therapeutic Procedure
67%
Thrombosis
15%
Treatment Duration
6%
Vagina Bleeding
15%
Venous Thromboembolism
62%
Woman
15%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulation Therapy
11%
Cohort Study
15%
Direct Oral Anticoagulant
14%
Fondaparinux
17%
Thrombin Inhibitor
15%
